Comparing site specific phospho-tau in normal and Alzheimer's disease brains
Are you looking for new tools for Alzheimer's diagnosis? Read here how phospho-tau modifications can be detected with ELISAs and potentially used as biomarkers.
The aetiology of neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, dementia and Creutzfeldt-Jakob disease are still not fully understood, and most existing drugs only treat symptoms. Further understanding of the molecular processes of these diseases in particular the triggers and early stages of the disease are important to identify potential new drugs. The presence and progressive accumulation of specific protein aggregates in the brain is the most defining feature across all major neurodegenerative diseases. Aggregation-prone proteins include α-synuclein, amyloid-β, tau, prion and polyglutamine-containing proteins. Solving the molecular basis of protein misfolding and aggregation is a crucial step towards the comprehension of the factors that trigger the onset of these diseases and for the development of efficient therapeutical strategies.
Besides human health, prion research has also an economic relevance as transmissible spongiform encephalopathies do not only affect humans but also livestock such as cattle and sheep.
Explore the content below to understand how BMG LABTECH instruments can support research in neurobiology including aggregation assays, viability assays and toxicity assays to assist in understanding neuronal death and in degeneration biomarker quantification.
Browse our resources section for information about specific applications, literature citations, videos, blog articles and many other publications. Many of the resources provided are associated with current and previous instrument models and versions.